Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 4, Pages 1084
Publisher
MDPI AG
Online
2022-02-22
DOI
10.3390/cancers14041084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the curative management of oesophageal cancer
- (2021) Jarlath C. Bolger et al. BRITISH JOURNAL OF CANCER
- Risk factors and consequences of anastomotic leakage after esophagectomy for cancer
- (2020) Eliza R.C. Hagens et al. ANNALS OF THORACIC SURGERY
- Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
- (2020) Takashi Kojima et al. JOURNAL OF CLINICAL ONCOLOGY
- Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
- (2020) Torben Glatz et al. Journal of Clinical Medicine
- Neoadjuvant therapy versus upfront surgery for clinical T2N0 esophageal cancer: A systematic review
- (2019) Biniam Kidane et al. ANNALS OF THORACIC SURGERY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis
- (2019) Shao-wu Jing et al. Future Oncology
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
- (2019) Ken Kato et al. LANCET ONCOLOGY
- Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options
- (2018) F.C. Mota et al. International Journal of Surgery
- ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
- (2016) Jens Hoeppner et al. BMC CANCER
- Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis
- (2016) Waresijiang Yibulayin et al. World Journal of Surgical Oncology
- Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy
- (2015) J. P. Dolan et al. DISEASES OF THE ESOPHAGUS
- Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis
- (2014) Arnulf H. Hölscher et al. EUROPEAN JOURNAL OF CANCER
- Multimodal treatment of locally advanced esophageal adenocarcinoma: Which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients
- (2013) Jens Hoeppner et al. JOURNAL OF SURGICAL ONCOLOGY
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
- (2012) F. Turati et al. ANNALS OF ONCOLOGY
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tobacco Smoking and Esophageal and Gastric Cardia Adenocarcinoma
- (2011) Irene Tramacere et al. EPIDEMIOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux
- (2010) J. H. Rubenstein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
- (2010) Bryan H. Burmeister et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
- (2009) William H. Allum et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
- (2008) Côme Lepage et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started